The Form 4 filing, an SEC report on insider share ownership, was submitted Nov. 3, 2026. That was one day after Kevin Holleran's sale.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-02 |
| Date of Latest Transaction | 2026-11-02 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 50,000 |
| Price | $16.55 |
| Total Transaction Value | $827,720.00 |
| Insider | |
| Ticker Symbol | HAYW |
| Company | Hayward Holdings, Inc. |
| Insider Name | HOLLERAN KEVIN |
| Insider Title | President and CEO |
| Sector - Industry | Other - Unclassified |
| Holdings | |
| Total Shares Owned After Transaction | 401,234 |
| Position Size Change | 11.08% |
| Filing | |
| Filing Date | 2026-11-03 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a share sale, reported with transaction code S. It is also marked as linked to an exercise or conversion, which uses code M. That can mean using a stock option's right to buy shares or turning another type of investment into shares.
What was the average price of the transaction?
The average sale price was $16.5544 per share. The transaction table shows this rounded to $16.55 per share.
How did this transaction affect the insider's holdings?
Kevin Holleran sold 50,000 shares and reported owning 401,234 shares afterward. The sale represented 11.08% of his shares held before the sale.
What's the total transaction value?
The reported sale totaled $827,720.00 across one transaction. No separate value for the linked exercise or conversion is available in the transaction details.
Are there any special circumstances around this transaction?
Yes. The sale is marked as tied to an exercise or conversion with the same share count in the same filing. The matching entry and filing footnotes were not provided. Its date, account, and type of investment cannot be confirmed from the available details. The matching share counts alone do not confirm that the exact shares received were sold or explain how the exercise was paid for.
For research purposes only; not investment advice.